StockData
CDT Equity Inc. logo

CDT Equity Inc. (CDT) stock

CDTNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CDTTW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.36−0.02 (-4.51%)

Close on Nov 17, 2026Market cap $283.20KP/E –Yield –

CDT Equity operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

CDT Equity's operating income for the twelve months ending Jun 30, 2026 was -$34.85M. For fiscal 2025 it was -$36.76M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$36.76M–
FY2024Dec 31, 2024-$15.42M–
FY2023Dec 31, 2023-$5.26M–
FY2022Dec 31, 2022-$3.16M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.00M–
Q1 FY2026Mar 31, 2026-$3.66M–
Q4 FY2025Dec 31, 2025-$21.16M–
Q3 FY2025Sep 30, 2025-$7.03M–
Q2 FY2025Jun 30, 2025-$4.95M–
Q1 FY2025Mar 31, 2025-$3.62M–
Q4 FY2024Dec 31, 2024-$3.51M–
Q3 FY2024Sep 30, 2024-$5.81M–
Q2 FY2024Jun 30, 2024-$3.14M–
Q1 FY2024Mar 31, 2024-$2.96M–
Q4 FY2023Dec 31, 2023-$2.43M–
Q3 FY2023Sep 30, 2023-$430.00K–
Q2 FY2023Jun 30, 2023-$888.00K–
Q1 FY2023Mar 31, 2023-$1.52M–
Q4 FY2022Dec 31, 2022-$1.67M–
Q3 FY2022Sep 30, 2022-$933.00K–
Q2 FY2022Jun 30, 2022-$279.42K–
Q1 FY2022Mar 31, 2022-$263.72K–

More CDT Equity figures

See a number that looks wrong?